The co-founder of Regeneron has warned that blockbuster weight-loss drugs could cause “more harm than good” unless the rapid muscle loss associated with the treatments is solved, as the US biotech pushes ahead with trials of muscle-preserving medicines.
再生元(Regeneron)的联合创始人警告称，除非解决与治疗相关的快速肌肉流失问题，否则畅销的减肥药物可能会“弊大于利”，因为美国生物技术公司正在推进保肌药物的试验。
您已阅读7%（338字），剩余93%（4297字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。